Endurant Capital Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-232,291
| Closed | -$590K | – | 66 |
|
|
2020
Q1 | $590K | Sell |
232,291
-802,342
| -78% | -$2.04M | 0.27% | 43 |
|
|
2019
Q4 | $3.6M | Buy |
1,034,633
+638,932
| +161% | +$2.22M | 1.13% | 25 |
|
|
2019
Q3 | $1.83M | Buy |
+395,701
| New | +$1.83M | 0.66% | 29 |
|
|
2019
Q1 | – | Sell |
-236,648
| Closed | -$2.04M | – | 75 |
|
|
2018
Q4 | $2.04M | Sell |
236,648
-325,936
| -58% | -$2.81M | 1.08% | 28 |
|
|
2018
Q3 | $4.21M | Buy |
562,584
+448,474
| +393% | +$3.36M | 1.87% | 22 |
|
|
2018
Q2 | $680K | Buy |
+114,110
| New | +$680K | 0.29% | 53 |
|
|
2016
Q3 | – | Sell |
-256,490
| Closed | -$2.32M | – | 99 |
|
|
2016
Q2 | $2.32M | Sell |
256,490
-286,800
| -53% | -$2.59M | 0.77% | 38 |
|
|
2016
Q1 | $4.38M | Buy |
543,290
+140,000
| +35% | +$1.13M | 1.42% | 29 |
|
|
2015
Q4 | $4.36M | Sell |
403,290
-94,478
| -19% | -$1.02M | 1.46% | 25 |
|
|
2015
Q3 | $4.04M | Buy |
497,768
+459,568
| +1,203% | +$3.73M | 1.35% | 26 |
|
|
2015
Q2 | $924K | Buy |
+38,200
| New | +$924K | 0.27% | 65 |
|